Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05357690 · ClinicalTrials.gov registry record · Phase 2

A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation

A Phase 2 study of Atrial Fibrillation, sponsored by Mayo Clinic.

Recruiting
Registry status
Phase 2
Development phase
220
Enrollment target
1
Study location

NCT05357690 is a Phase 2 study of Atrial Fibrillation that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 220 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05357690, a Phase 2 study of Atrial Fibrillation, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
Phase 2
Development phase
220 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test if a nerve block procedure called a stellate ganglion block can help decrease the chance of atrial fibrillation after surgery. Atrial fibrillation is the abnormal, fast beating of the upper chambers of the heart. Stellate ganglion blockade has shown to decrease other types of abnormal heart rhythms as well as decrease the chance of atrial fibrillation.

Conditions Studied

Atrial Fibrillation

Interventions

  • DRUG Placebo
  • DRUG Bupivacaine
  • PROCEDURE Stellate ganglion block

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2023-04-19
Est. Completion 2026-12
Phase Phase 2

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05357690

The ClinicalTrials.gov registry entry for NCT05357690 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (93% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT05357690 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05357690 about?

NCT05357690 is a clinical study titled "A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation". The purpose of this study is to test if a nerve block procedure called a stellate ganglion block can help decrease the chance of atrial fibrillation after surgery. Atrial fibrillation is the abnormal, fast beating of the upper chambers of the heart. Stellate ganglion blockade has shown to decrease o...

What is the current status of trial NCT05357690?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 220 participants. The study started on 2023-04-19. Estimated completion is 2026-12.

What conditions does trial NCT05357690 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT05357690?

The interventions under investigation include: Placebo (DRUG), Bupivacaine (DRUG), Stellate ganglion block (PROCEDURE).

Who is sponsoring clinical trial NCT05357690?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05357690 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.